The hemodynamic determinants of the isovolumic index

The isovolumic index is a recently described echocardiographic parameter of left ventricular function that is calculated as the ratio between the sum of the time of isovolumic contraction and relaxation divided by the ejection time. Although the individual components of this index may be altered by heart rate and loading conditions, an analysis of the net effect of such alterations on the isovolumic index has not been undertaken. Thus, dogs were instrumented with high-fidelity micromanometers in the left ventricle, ascending aorta, and left atrium to allow determination of the individual comoonents of the isovolumic index and calculation of the index itself. Four sets of experiments were undertaken in random order. Left atrial pacing was used to increase heart rate by approximately 10 bpm in five steps. Preload was elevated in five stages by saline infusions which caused successive increases of 1 to 2 mm Hg in the left ventricular end-diastolic pressure. Systolic blood pressure was lowered or raised by approximately 10 mm Hg per stage by three progressive, steady-state infusions of nitroprusside and phenylephrine, respectively. These experiments demonstrated little change in the isovolumic index over a broad range of heart rate. Increased left ventricular end-diastolic pressure and decreased systemic pressure caused shortening of the index. Multiple regression analysis of all experiments yielded the following: isovolumic INDEX = 0.41 - 0.015 (left ventricular end-diastolic pressure) + 0.004 (systolic blood pressure); r = 0.57, standard ERROR = 0.13, p < 0.0001. Therefore, this investigation establishes the hemodynamic determinants of the isovolumic index and provides the basis for interpretation of directional changes in response to cardiac diseases and cardioactive drugs that can alter loading conditions.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/26036/1/0000109.pd

Relation between graded, subcritical impairments of coronary flow reserve and regional myocardial dysfunction induced by isoproterenol infusion in dogs

Isoproterenol has been used experimentally and clinically to elicit ischemia. The usefulness of this approach, however, in eliciting regional dysfunction in the presence of mild to moderate single-vessel coronary disease quantitated on the basis of coronary flow reserve measurements has not been previously defined. Open-chest, anesthetized dogs were instrumented with an electromagnetic flow probe, high-fidelity micromanometers, and subendocardial ultrasonic crystals. A rigid, screw occluder was used to produce five subcritical coronary stenoses in each dog associated with varying impairment of postocclusion reactive hyperemia at rest but no impairment of resting coronary blood flow. Regional function at rest and in response to the isoproterenol challenge (0.25 [mu]g/kg/min) in nonstenotic and stenotic conditions was assessed. Relative regional function was maintained during the infusion until nearly total loss of coronary flow reserve. With this near-critical stenosis, function was lower than in the nonstenotic state but remained greater than resting control values. Moderate impairments of coronary flow reserve were not associated with isoproterenol-induced deterloration of regional function. In conclusion, detection of impaired coronary flow reserve at rest is a more sensitive index of the severity of a coronary stenosis than is detection of regional dysfunction during isoproterenol challenge. Fallure to maintain the expected isoproterenol-induced increase in regional function is manifested only when stenoses are associated with nearly total loss of resting coronary flow reserve. This suggests that the clinical use of isoproterenol challenge is not effective in eliciting regional dysfunction when mild coronary disease is present.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/26766/1/0000318.pd